TNF alpha antibody – The TNF (Tumor Necrosis Factor) Alpha is a multifunctional pro-inflammatory adipokine, a cell signaling protein secreted by adipose tissue, involved in systemic inflammation and stimulation of the acute phase reaction. It is is a potent lymphoid factor that exerts cytotoxic effects on a wide range of tumor cells and certain other target cells.This protein is primarily produced as a type two transmembrane protein arranged in stable homotrimers. This membrane bound form of the protein is then proteolytically cleaved into the secreted form of TNF alpha, both the secreted and membrane bound protein are biologically active. The adipokine can bind two TNF receptors. The first receptor is expressed in most tissues and can interact and be activated by both forms of the TNF protein. While, in contrast, the second TNF receptor is only found in immune cells and respond to the membrane bound form of the TNF protein.
While is can be secreted by many cells types, including CD4+ lymphocytes, natural killer cells and neurons; this adipokine is produced primarily by activated macrophages. TNF alphas primary role is the regulation of immune cells. The adipokine is also an endogenous pyrogen and is able to induce fever both directly and via stimulation of interleukin secretion, apoptotic cell death, cachexia (wasting syndrome), inflammation and tumorigenesis (carcinogenesis) and viral replication inhibition. TNF alpha has been implicated in a variety of illnesses, such as cancer, insulin resistance, and autoimmune diseases.
Tumor Necrosis Factor promotes an inflammatory response to remove harmful stimuli, which include damaged cells, irritants, or pathogens, and then begins the therapeutic process. The inflammatory response is generally in response to a foreign pathogen but in some cases, excessive inflammation may be indicative of an autoimmune disease and other disorders. Some examples of autoimmune diseases are ankylosing spondylitis (chronic inflammatory disease of the axial skeleton), Crohn’s disease (inflammatory bowel disease), psoriasis (lifelong condition that affects the skin), hidradenitis suppurativa (skin diseases) and asthma (known as refractory asthma, if the symptoms persist long-term).
Additionally, TNF alpha can be a gateway to provide a biological therapy to patients as it is a proinflammatory cytokine that has been implicated in many aspects of the airway pathology in asthma, and can potentially be a significant factor in refractory asthma (persistent symptoms). This is completed by inducing either an increase in resistance or a decrease in driving pressure. As a result, TNA alpha antibody can be used as a therapeutic option for patients by increasing the resistance of the autoimmune disease, which will increase airway responsiveness.
The biotechnology industry is the operation of biological processes for scientific reagents and for other scientific functions. Fundamentally, biological reagents are mechanisms that are used in biochemical analysis to assess biological processes. It can be used to produce antibodies that are used to target a particular protein target, which are known as antigens.
The host of the TNF alpha antibody is a rabbit, and it reacts withhuman, mouse and rat. The antibody can be used on the following applications, WB (western blot), and IHC-P (immunohistochemistry).